Skip to content
Open access · CC-BY via OpenAlex

Rapamycin-induced hyperglycemia is associated with exacerbated age-related osteoarthritis

Dennis M. Minton, Christian J. Elliehausen, Martin A. Javors, Kelly S. Santangelo, Adam R. Konopka

Arthritis Research & Therapy · 2021 · ▲ 16 citations

Abstract

BACKGROUND: The objective of this study was to determine if mechanistic target of mTOR(definition)-inhibiting drug studied for extending healthspan and lifespan." style="text-decoration:underline dotted; text-underline-offset:2px; cursor:help;">rapamycin(definition) (mTOR) inhibition with or without AMP-activated protein kinase (AMPK) activation can protect against primary, age-related OA. DESIGN: Dunkin-Hartley guinea pigs develop mild primary OA pathology by 5 months of age that progresses to moderate OA by 8 months of age. At 5 months, guinea pigs served as young control (n = 3) or were fed either a control diet (n = 8), a diet enriched with the mTOR-inhibitor rapamycin (Rap, 14 ppm, n = 8), or Rap with the AMPK-activator metformin (Rap+Met, 1000 ppm, n = 8) for 12 weeks. Knee joints were evaluated by OARSI scoring, micro-computed tomography, and immunohistochemistry. Glenohumeral articular cartilage was collected for western blotting. RESULTS: Rap- and Rap+Met-treated guinea pigs displayed lower body weight than control. Rap and Rap+Met inhibited articular cartilage mTORC1 but not mTORC2 signaling. Rap+Met, but not Rap alone, stimulated AMPK. Despite lower body weight and articular cartilage mTORC1 inhibition, Rap- and Rap+Met-treated guinea pigs had greater OA severity in the medial tibial plateau due to articular cartilage structural damage and/or proteoglycan loss. Rap and Rap+Met increased plasma glucose compared to control. Plasma glucose concentration was positively correlated with proteoglycan loss, suggesting hyperglycemic stress after Rap treatment was related to worsened OA. CONCLUSIONS: This is the first study to show that Rap induced increase in plasma glucose was associated with greater OA severity. Further, articular cartilage mTORC1 inhibition and bodyweight reduction by dietary Rap and Rap+Met did not appear to protect against primary OA during the prevailing hyperglycemia.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.1186/s13075-021-02637-1
Canonical
link ↗
Fetched
2026-10-29 MST

Cite this

APA
Minton, D.M., Elliehausen, C.J., Javors, M.A., Santangelo, K.S., &amp; Konopka, A.R. (2021). Rapamycin-induced hyperglycemia is associated with exacerbated age-related osteoarthritis. <em>Arthritis Research & Therapy</em>. https://doi.org/10.1186/s13075-021-02637-1
Vancouver
Minton DM, Elliehausen CJ, Javors MA, Santangelo KS, Konopka AR. Rapamycin-induced hyperglycemia is associated with exacerbated age-related osteoarthritis. Arthritis Research & Therapy. 2021. doi:10.1186/s13075-021-02637-1.
BibTeX
@article{dennis2021Rapamy, title = {Rapamycin-induced hyperglycemia is associated with exacerbated age-related osteoarthritis}, author = {Dennis M. Minton and Christian J. Elliehausen and Martin A. Javors and Kelly S. Santangelo and Adam R. Konopka}, journal = {Arthritis Research & Therapy}, year = {2021}, doi = {10.1186/s13075-021-02637-1}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings